Delivery Order SPE2DX22D0099-SPE2D825FAQ4B
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $5,739.90 to AmerisourceBergen Drug Corp on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $110,752.60 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $118,601.30 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order was competitively awarded without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $275,118.44 to AmerisourceBergen Drug Corp on August 23, 2025, for pharmaceutical and medical supply delivery. This firm fixed price delivery order, which concludes August 25, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, valued at $3,634.86, represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026. AmerisourceBergen, a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $27,768.48 to AmerisourceBergen Drug Corp on July 9, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $45,142.44 to AmerisourceBergen Drug Corp on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,379.98 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The award is performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D825FAQ4BDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $55,543.32 to AmerisourceBergen Drug Corp on August 4, 2025, under a firm fixed-price contract with an ultimate completion date of August 5, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal military and veteran healthcare systems. The company supplies a comprehensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is part of AmerisourceBergen's broader role as a pharmaceutical prime vendor supporting global military healthcare programs. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the flexible IDC vehicle. As one of multiple contractors anticipated for the DLA's Pharmaceutical Prime Vendor Global Program Generation V regional contracts, AmerisourceBergen continues to serve as a critical supplier ensuring pharmaceutical product availability and distribution across the military medical infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.5k | 8/4/25 |